The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors
Open accessAbstract
Some Candida albicans isolates from AIDS patients with oropharyngeal candidiasis are becoming resistant to the azole antifungal agent fluconazole after prolonged treatment with this compound. Most of the C. albicans isolates resistant to fluconazole fail to accumulate this antifungal agent, and this has been considered a cause of resistance. This phenomenon was shown to be linked to an increase in the amounts of mRNA of a C. albicans ABC (ATP-binding cassette) transporter gene called CDR1 and of a gene conferring benomyl resistance (BENr), the product of which belongs to the class of major facilitator multidrug efflux transporters (D. Sanglard, K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille, Antimicrob. Agents Chemother. 39:2378-2386, 1995). To analyze the roles of these multidrug transporters in the efflux of azole antifungal agents, we constructed C. albicans mutants with single and double deletion mutations of the corresponding genes. The mutants were tested for their susceptibilities to these antifungal agents. Our results indicated that the delta cdr1 C. albicans mutant was hypersusceptible to the azole derivatives fluconazole, itraconazole, and ketoconazole, thus showing that the ABC transporter Cdr1 can use these compounds as substrates. The delta cdr1 mutant was also hypersusceptible to other antifungal agents (terbinafine and amorolfine) and to different metabolic inhibitors (cycloheximide, brefeldin A, and fluphenazine). The same mutant was slightly more susceptible than the wild type to nocodazole, cerulenin, and crystal violet but not to amphotericin B, nikkomycin Z, flucytosine, or pradimicin. In contrast, the delta ben mutant was rendered more susceptible only to the mutagen 4-nitroquinoline-N-oxide. However, this mutation increased the susceptibilities of the cells to cycloheximide and cerulenin when the mutation was constructed in a delta cdr1 background. The assay used in the present study could be implemented with new antifungal agents and is a powerful tool for assigning these substances as putative substrates of multidrug transporters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,687
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 877
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Self-citationPrasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Johnson, E. M., Warnock, D. W., Luker, J., Porter, S. R., & Scully, C. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.1.103 · Cited by 259
Molecular mechanisms of drug resistance in fungi
Vanden Bossche, H., Marichal, P., & Odds, F. C. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90618-1 · Cited by 254
Human Mycoses: Drugs and Targets for Emerging Pathogens
Georgopapadakou, N. H., & Walsh, T. J. (1994) · Science · doi:10.1126/science.8153622 · Cited by 232
Bissinger, P. H., & Kuchler, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41760-1 · Cited by 231
Fling, M. E., Kopf, J., Tamarkin, A., Gorman, J. A., Smith, H. A., & Koltin, Y. (1991) · Molecular and General Genetics MGG · doi:10.1007/bf00259685 · Cited by 204
Studies on the mode of action of hygromycin B, an inhibitor of translocation in eukaryotes
González, A., Jiménez, A., Vázquez, D., Davies, J. E., & Schindler, D. (1978) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(78)90287-3 · Cited by 176 · cited 1×
“These substances were amphotericin B (a membrane-destabilizing compound) (11), flucytosine (a toxic pyrimidine analog) (18), nikkomycin Z (a chitin synthase inhibitor) (30), pradimicin (which binds to mannan in the presence of Ca(21)) (10), griseofulvin (an inhibitor of microtubule aggregation) (18), hygromycin B (a p…”
BackgroundDecottignies, A., Lambert, L., Catty, P., Degand, H., Epping, E. A., Moye-Rowley, W. S., Balzi, E., & Goffeau, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.18150 · Cited by 162
Genetics and biochemistry of yeast multidrug resistance
Balzi, E., & Goffeau, A. (1994) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(94)90102-3 · Cited by 152
Mode of Action of Clinically Important Antifungal Drugs
Kerridge, D. (1986) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60303-3 · Cited by 143
Specificity of deoxyribonucleic acid cleavage by bleomycin, phleomycin, and tallysomycin
Kross, J., Henner, W. D., Hecht, S. M., & Haseltine, W. A. (1982) · Biochemistry · doi:10.1021/bi00261a021 · Cited by 116
Graham, T. R., Scott, P. A. E., & Emr, S. D. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05727.x · Cited by 105
Clark, F. S., Parkinson, T., Hitchcock, C. A., & Gow, N. A. R. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.419 · Cited by 101
Multidrug resistance in Candida albicans: disruption of the BENr gene
Goldway, M., Teff, D., Schmidt, R., Oppenheim, A., & Koltin, Y. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.422 · Cited by 89
Nelissen, B., Mordant, P., Jonniaux, J., Wächter, R. D., & Goffeau, A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01380-6 · Cited by 82
Sensitivity to nikkomycin Z in Candida albicans: role of peptide permeases
Yadan, J., Gonneau, M., Sarthou, P., & Goffic, F. L. (1984) · Journal of Bacteriology · doi:10.1128/jb.160.3.884-888.1984 · Cited by 78
The role of microfilaments and microtubules in apical growth and dimorphism of Candida albicans
Yokoyama, K., Kaji, H., Nishimura, K., & Miyaji, M. (1990) · Journal of General Microbiology · doi:10.1099/00221287-136-6-1067 · Cited by 70
Epidemiology of Candida Infections in Aids
Odds, F. C., Schmid, J., & Soll, D. R. (1990) · Springer eBooks · doi:10.1007/978-1-4613-0655-9_5 · Cited by 61
Powderly, W. G. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.925 · Cited by 51
Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients
Vuffray, A., Durussel, C., Boerlin, P., Boerlin-Petzold, F., Bille, I., Glauser, M. P., & Chave, J. P. (1994) · AIDS · doi:10.1097/00002030-199405000-00023 · Cited by 48
Effect of side‐chain structure on inhibition of yeast fatty‐acid synthase by cerulenin analogues
Morisaki, N., Funabashi, H., Shimazawa, R., FURUKAWA, J., KAWAGUCHI, A., Okuda, S., & Iwasaki, S. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19876.x · Cited by 46
In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184
Fung-Tomc, J. C., Minassian, B., Huczko, E., Kolek, B., BONNER, D. P., & KESSLER, R. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.295 · Cited by 46
Ehrenhofer‐Murray, A. E., Würgler, F. E., & Sengstag, C. (1994) · Molecular and General Genetics MGG · doi:10.1007/bf00285456 · Cited by 45
Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin.
Wn, H., Gesmonde, J. F., & Js, L. (1994) · PubMed · Cited by 38
ATP binding cassette transporters in yeast
Egner, R., Mahé, Y., Pandjaitan, R., Huter, V., Lamprecht, A., & Kuchler, K. (1995) · Membrane protein transport · doi:10.1016/s1874-592x(06)80004-1 · Cited by 17
Cited by
Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,785
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Self-citationWhite, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Efflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608
Metadata
- Authors
- Sanglard, D., Ischer, F., Monod, M., & Bille, J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1996-10
- Volume
- 40
- Issue
- 10
- Pages
- 2300-2305
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2097149581
- Cited by
- 402
- References
- 28
- FWCI
- 19.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.